Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
24.70%
Grew
—
—
Grew
—
1 Year
Score—
Net Growth24.70%
Net TrendGrew
Net Income Consistency—
Rev Growth—
Rev TrendGrew
Revenue Consistency—
5 Years
—
-111.04%
60%
—
—
20%
—
5 Years
Score—
Net Growth-111.04%
Net Trend60%
Net Income Consistency—
Rev Growth—
Rev Trend20%
Revenue Consistency—
Vincerx Pharma, Inc. Common Stock fundamental performance
Across Vincerx Pharma, Inc. Common Stock's full reported history, from 2020 to 2024, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 10M to -$ 30M. Revenue increased in 20% of the years measured; net income in 60%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-11 | $ 0.01 | — |
1 Year2025-08-12 | $ 0.04 | -65.68% |
5 Years2021-08-12 | $ 234.60 | -99.99% |
All Time2020-05-27 | $ 187.00 | -99.99% |
| Period | Last Price2026-08-11 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2020-05-27 |
|---|---|---|---|---|
| Price | $ 0.01 | $ 0.04 | $ 234.60 | $ 187.00 |
| Return | — | -65.68% | -99.99% | -99.99% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 1M | -$ 22M | $ 4M |
| 2024 | $ 0.00 | -$ 30M | $ 4M |
| 2023 | $ 0.00 | -$ 40M | $ 12M |
| 2022 | $ 0.00 | -$ 65M | $ 52M |
| 2021 | $ 0.00 | -$ 39M | $ 111M |
| IPO2020 | $ 0.00 | -$ 10M | $ 61M |
Explore beyond VINC
You're looking at Vincerx Pharma, Inc. Common Stock. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
